United States Patent Rights for Apellis Products

In accordance with 35 USC § 287(a), the following list identifies certain Apellis products marketed in the United States and associated U.S. patents. This list may not be exhaustive, and other patents may be pending.

EMPAVELI™ (pegcetacoplan) injection, for subcutaneous use

U.S. Patent No. 7,888,323
U.S. Patent No. 7,989,589
U.S. Patent No. 9,169,307
U.S. Patent No. 10,035,822
U.S. Patent No. 10,125,171
U.S. Patent No. 10,875,893

Date: 05/14/21